AM Squared’s Zimmer Biomet ZBH Stock Holding History

AM Squared’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$75.6K	Buy	700 +300	+75%	+$32.7K	0.17%	50
2024 Q2	$43.4K	Buy	+400	New	+$47.2K	0.11%	59

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

AM Squared's ZBH Position: Q3 2024 in Review

AM Squared increased its Zimmer Biomet (ZBH) stake by 75% in Q3 2024, buying an estimated $32.7K and bringing the position to 700 shares worth $75.6K. The position accounts for 0.17% of the portfolio, ranked #50.

AM Squared first reported a position in ZBH in Q2 2024 and has held it in 2 quarters since. 983 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

AM Squared held 700 shares of Zimmer Biomet worth $75.6K as of Q3 2024.
AM Squared bought 300 Zimmer Biomet shares in Q3 2024, an estimated $32.7K.
Zimmer Biomet made up 0.17% of AM Squared's portfolio in Q3 2024, its #50 holding.
AM Squared first reported a position in Zimmer Biomet in Q2 2024 and has held it in 2 quarters since.
983 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.